Loading organizations...
Biopharmaceutical company regulating oxygen and hemoglobin binding.
NormOxys has raised $17.5M across 1 funding round.
NormOxys has raised $17.5M in total across 1 funding round.
NormOxys has raised $17.5M in total across 1 funding round.
NormOxys's investors include Jerry Karabelas, Index Ventures.
NormOxys has raised $17.5M across 1 funding round. Most recently, it raised $17.5M Series B in May 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 24, 2010 | $17.5M Series B | Jerry Karabelas | Index Ventures |